Pharmacological analysis of the novel, selective α1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand

British Journal of Pharmacology

Volumn 127, Issue 1, 1999, Pages 19-26

  Murata, Satoshi ^a,b   Taniguchi, Takanobu ^a   Muramatsu, Ikunobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

KMD 3213; Prazosin; Tamsulosin; 1 adrenoceptor subtypes

Indexed keywords

3' (2 AMINO 1 HYDROXYETHYL) 4' FLUOROMETHANESULFONANILIDE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN; PRAZOSIN; RADIOLIGAND; RECOMBINANT PROTEIN; SILODOSIN; TAMSULOSIN; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTERY; ARTERY CONSTRICTION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; KIDNEY; LIVER; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SUBMANDIBULAR GLAND; THORACIC AORTA;

EID: 0032949613     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702489     Document Type: Article

References (37)

1. Arunlakshana, O. & Schild, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., 14, 48-58.
2. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
3. Bylund, D.B., Bond, R.A., Clarke, D.E., Eikenbur, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Molinof, P.B., Ruffolo, R.R., Strosberg, A.D. & Trendelenburg, U.G. (1998). ADRENOCEPTORS. In The IUPHAR Compendium of Receptor Characterization and Classification, pp. 58-74.
4. Bylund, D.B., Eikenberg, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Molinoff, P.B., Ruffolo, R.R. & Trendelenburg, U.G. (1994). International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev., 46, 121-136.
5. Bylund, D.B., Regan, J.W., Faber, J.E., Hieble, J.P., Triggle, C.R. & Ruffolo, R.J. (1995). Vascular alpha-adrenoceptors: from the gene to the human. Can. J. Physiol. Pharmacol., 73, 533-543.
6. Chang, D.J., Chang, T.K., Yamanishi, S.S., Salazar, F.H., Kosaka, A.H., Khare, R., Bhakta, S., Jasper, J.R., Shieh, I.S., Lesnick, J.D., Ford, A.P., Daniels, D.V., Eglen, R.M., Clarke, D.E., Bach, C. & Chan, H.W. (1998). Molecular cloning, genomic characterization and expression of novel human alpha 1A-adrenoceptor isoforms. FEBS Lett., 422, 279-283.
7. Daniels, D.V., Gever, J.R., Meloy, T.D., Chang, D.J., Kosaka, A.H., Clarke, D.E. & Ford, A.P. (1996). Functional pharmacological characteristics of human, rat and rabbit cloned alpha 1A-adrenoceptors expressed in Chinese hamster ovary (CHO-K1) cells. Br. J. Pharmacol., 119, 360P.
8. Feng, F., Pettinger, W.A., Abel, P.W. & Jeffries, W.B. (1991). Regional distribution of alpha 1-adrenoceptor subtypes in rat kidney. J. Pharmacol. Exp. Ther., 258, 263-268.
9. Flavahan, N.A. & Vanhoutte, P.M. (1986). Alpha-adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol. Sci., 7, 347-349.
10. Ford, A.P., Arredondo, N.F., Blue, D.J., Bonhaus, D.W., Jasper, J., Kava, M.S., Lesnick, J., Pfister, J.R., Shieh, I.A., Vimont, R.L., Williams, T.J., Mcneal, J.E., Stamey, T.A. & Clarke, D.E. (1996). RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol. Pharmacol., 49, 209-215.
11. Ford, A.P.D.W., Daniels, D.V., Chang, D.J., Gever, J.R., Jasper, J.R., Lesnick, J.D. & Clarke, D.E. (1997). Pharmacological pleiotropism of the human recombinant alpha A-adrenoceptor: implications for alpha 1-adrenoceptor classification. Br. J. Pharmacol., 121, 1127-1135.
12. Graham, R.M., Perez, D.M., Hwa, J. & Piascik, M.T. (1996). Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ. Res., 78, 737-749.
13. Han, C., Abel, P.W. & Minneman, K.P. (1987). Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing Ca2+ in smooth muscle. Nature, 329, 333-335.
14. Han, C., Hollinger, S., Theroux, T.L., Esbenshade, T.A. & Minneman, K.P. (1995). 3H-Tamsulosin binding to clonal alpha 1-adrenergic receptor subtypes expressed in human embryonic kidney 293 cells: antagonist potencies and sensitivity to alkylating agents. Pharmacol. Commun., 5, 117-126.
15. Hieble, J.P., Bylund, D.B., Clarke, D.E., Eikenburg, D.C., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P. & Ruffolo, R.J. (1995). International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol. Rev., 47, 267-270.
16. Hirasawa, A., Shibata, K., Horie, K., Takei, Y., Obika, K., Tanaka, T., Muramoto, N., Takagaki, K., Yano, J. & Tsujimoto, G. (1995). Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants. FEBS Lett., 363, 256-260.
17. Kava, M.S., Blue, D.J., Vimont, R.L., Clarke, D.E. & Ford, A.P. (1998). Alpha 1L-adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man. Br. J. Pharmacol., 123, 1359-1366.
18. Kenny, B.A., Chalmers, D.H., Philpott, P.C. & Naylor, A.M. (1995). Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol., 115, 981-986.
19. Lachnit, W.G., Tran, A.M., Clarke, D.E. & Ford, A.P. (1997). Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br. J. Pharmacol., 120, 819-826.
20. Mcgrath, J.C. (1982). Evidence for more than one type of post-junctional alpha-adrenoceptor. Biochem. Pharmacol., 31, 467-484.
21. Michel, A.D., Loury, D.N. & Whiting, R.L. (1989). Identification of a single alpha 1-adrenoceptor corresponding to the alpha 1A-subtype in rat submaxillary gland. Br. J. Pharmacol., 98, 883-889.
22. Minneman, K.P. (1988). Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell calcium. Pharmacol. Rev., 40, 87-119.
23. Moriyama, N., Akiyama, K., Murata, S., Taniguchi, J., Ishida, N., Yamazaki, S. & Kawabe, K. (1997). KMD-3213, a novel alpha 1A-adrenoceptor antagonist, potently inhibits the functional alpha 1-adrenoceptor in human prostate. Eur. J. Pharmacol., 331, 39-42.
24. Morrow, A.L. & Creese, I. (1986). Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4101 and [3H]prazosin binding. Mol. Pharmacol., 29, 321-330.
25. Munson, P.J. & Rodbard, D. (1980). Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
26. Muramatsu, I., Kigoshi, S. & Ohmura, T. (1991). Subtypes of alpha 1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery. Jpn. J. Pharmacol., 57, 535-544.
27. Muramatsu, I., Ohmura, T., Hashimoto, S. & Oshita, M. (1995). Functional subclassification of vascular alpha 1-adrenoceptors. Pharmacol. Commun., 6, 23-28.
28. Muramatsu, I., Ohmura, T., Kigoshi, S., Hashimoto, S. & Oshita, M. (1990). Pharmacological subclassification of alpha 1-adrenoceptors in vascular smooth muscle. Br. J. Pharmacol., 99, 197-201.
29. Obika, K., Shibata, K., Horie, K., Foglar, R., Kimura, K. & Tsujimoto, G. (1995). NS-49, a novel alpha 1a-adrenoceptor-selective agonist characterization using recombinant human alpha 1-adrenoceptors. Eur. J. Pharmacol., 291, 327-334.
30. Ohmura, T., Oshita, M., Kigoshi, S. & Muramatsu, I. (1992). Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Br. J. Pharmacol., 107, 697-704.
31. O'Malley, S.S., Chen, T.B., Francis, B.E., Gibson, R.E., Burns, H.D., Disalvo, J., Bayne, M.L., Wetzel, J.M., Nagarathnam, D., Marzabadi, M., Gluchowski, C. & Chang, R.S. (1998). Characterization of specific binding of [125I]L-762,459, a selective alpha 1A-adrenoceptor radioligand to rat and human tissues. Eur. J. Pharmacol., 348, 287-295.
32. Oshita, M., Kigoshi, S. & Muramatsu, I. (1991). Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex. Br. J. Pharmacol., 104, 961-965.
33. Shibata, K., Foglar, R., Horie, K., Obika, K., Sakamoto, A., Ogawa, S. & Tsujimoto, G. (1995). KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. Mol. Pharmacol., 48, 250-258.
34. Testa, R., Guarneri, L., Taddei, C., Poggesi, E., Angelico, P., Sartani, A., Leonardi, A., Gofrit, O.N., Meretyk, S. & Caine, M. (1996). Functional antagonistic activity of Rec 15/ 2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery. J. Pharmacol. Exp. Ther., 277, 1237 1246.
35. Williams, T.J., Clarke, D.E. & Ford, A.P. (1996). Whole-cell radioligand binding assay reveals alpha 1L-adrenoceptor (AR) antagonist profile for the human cloned alpha 1A-AR in chinese hamster ovary (CHO-K1) cells. Br. J. Pharmacol., 119, 359P.
36. Yamagishi, R., Akiyama, K., Nakamura, S., Hora, M., Masuda, N., Matsuzawa, A., Murata, S., Ujiie, A., Kurashina, Y., Iizuka, K. & Kitazawa, M. (1996). Effect of KMD-3213, an alpha 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta. Eur. J. Pharmacol., 315, 73-79.
37. Yang, M., Verfurth, F., Bushcer, R. & Michel, M.C. (1997). Is alpha 1D-adrenoceptor protein detectable in rat tissues? Naunyn-Schmiedeberg's Arch Pharmacol., 355, 438-446.